Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Current synopsis: The source: cannabinoids

Jill Woodworth

To manage a diagnosis of TSC one must broaden the scope of germ theory. Focusing on individual manifes­tations without overall integration and oversight of all specialists treating requires solid supports and intricate case management overtime to gain any measure of sta­bility, minimize the impact of manifestations and maintain overall health. Quality of life is significantly strained and diminished over time in many cases as support networks become more siloed, with all communication between providers implemented by a caregiver. Medications are prescribed by multiple parties with little long-term over­sight of cumulative side effects and interactions over time. One must become subservient to the healthcare systems inclusive of behavioural and mental health services, as well as educational settings. The assumption that the profes­sionals from whom we are seeking treatment and support know more about the condition and therefore the key to case management is wrangling experts in specialities and seeking to integrate the most progressive research and treatments, all while holding on to intense patient history and respectfully bow to the top-heavy power struc­ture of modern medicine to guide. There is less of a top-heavy power structure and the use of cannabinoid medi­cine requires much patient involvement and education so eventually, it is managed solely by the individual.